Detection of Helicobacter pylori in gastric cancer tissue through histopathology, immunohistochemistry and real-time reverse transcription-PCR

Author:

A Castaneda Carlos12ORCID,Castillo Miluska3ORCID,Sanchez Joselyn3ORCID,Casavilca Sandro4ORCID,Sanchez Juvenal4ORCID,A Bernabe Luis3ORCID,Suarez Nancy3ORCID,Chavez Ivan5ORCID,Ruiz Eloy5ORCID,Tello Katherine3ORCID,R Villa Maria4ORCID,Zevallos Rocio4ORCID,Montenegro Paola1ORCID,Dias-Neto Emmanuel6ORCID,Landa-Baella Maria3ORCID,Taxa Luis4ORCID

Affiliation:

1. Departamento de Oncología Médica, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Peru

2. Facultad de Ciencias de la Salud, Universidad Científica del Sur, Lima 15067, Peru

3. Departamento de Investigación, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Peru

4. Departamento de Patología, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Peru

5. Departamento de Abdomen, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Peru

6. Laboratory of Medical Genomics, CIPE, A.C. Camargo Cancer Center, São Paulo 04002-010, Brasil

Abstract

Aim: Helicobacter pylori is usually detected based on hematoxylin–eosin (H–E) features, but, immunohistochemistry (IHC) and real-time PCR (RT-PCR) are more precise in chronic-gastritis. We evaluated the relevance of these tests in Peruvian gastric cancer samples. Materials & methods: We performed and evaluated H–E, IHC staining and RT-PCR in 288 gastric tumors. Slides were independently evaluated by three pathologists. Results: H. pylori was detected in 167/287 through H–E, 140/288 through IHC and 175/288 through RT-PCR, and positive-status were associated (p < 0.001). H. pylori detection by H–E had a good concordance with IHC (kappa index = 0.632) but poor with RT-PCR (kappa index = 0.317). Higher median gene-copies were found in high H. pylori density through H–E or IHC (p < 0.001). Conclusion: H–E evaluation is accurate in gastric cancer, and IHC and RT-PCR can complement its results.

Funder

Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica

Publisher

Future Medicine Ltd

Subject

Microbiology (medical),Microbiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3